- Our sense is price erosion in derma may have increased (as alluded by Alembic for their derma JV Aleor) which may be reason for lower gross margin - slight negative read out for SUNP, reporting on 30th" name="description">
- Our sense is price erosion in derma may have increased (as alluded by Alembic for their derma JV Aleor) which may be reason for lower gross margin - slight negative read out for SUNP, reporting on 30th" />
- Our sense is price erosion in derma may have increased (as alluded by Alembic for their derma JV Aleor) which may be reason for lower gross margin - slight negative read out for SUNP, reporting on 30th" />
- Our sense is price erosion in derma may have increased (as alluded by Alembic for their derma JV Aleor) which may be reason for lower gross margin - slight negative read out for SUNP, reporting on 30th" />
 
Latest Post

Research

Taro Q1 FY22 result - key highlights - YES Securities



Posted On : 2021-08-01 10:59:22( TIMEZONE : IST )

Taro Q1 FY22 result - key highlights - YES Securities

- Sales up 25% yoy to US$147mn on a pandemic disrupted base of last year

- Gross margin lower at 53% despite a more regular revenue figure vs 55% last year

- No change in commentary - "challenging landscape continues with uncertainty due to recent uptick in COVID cases"

- Our sense is price erosion in derma may have increased (as alluded by Alembic for their derma JV Aleor) which may be reason for lower gross margin - slight negative read out for SUNP, reporting on 30th.

Shares of SUN PHARMACEUTICAL INDUSTRIES LTD. was last trading in BSE at Rs. 774 as compared to the previous close of Rs. 703.25. The total number of shares traded during the day was 2034169 in over 51113 trades.

The stock hit an intraday high of Rs. 780.1 and intraday low of 696.15. The net turnover during the day was Rs. 1525828277.

Source : Equity Bulls

Keywords